{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:05:34Z","timestamp":1792494334525,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,6]],"date-time":"2011-11-06T00:00:00Z","timestamp":1320537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/ng.1004","type":"journal-article","created":{"date-parts":[[2011,11,6]],"date-time":"2011-11-06T18:40:28Z","timestamp":1320604828000},"page":"1256-1261","source":"Crossref","is-referenced-by-count":518,"title":["Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome"],"prefix":"10.1038","volume":"43","author":[{"given":"Twinkal C","family":"Pansuriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio","family":"d'Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayke A J H","family":"van Ruler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke L","family":"Kuijjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Oosting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Cleton-Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolieke G","family":"van Oosterwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie L J","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin H","family":"Nord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sangiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkin","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Liegl-Atzwanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"San-Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raf","family":"Sciot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Gunnar","family":"Kindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soeren","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godfraind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miikka","family":"Vikkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle C","family":"Kurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly","family":"Szuhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim J","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith V M G","family":"Bov\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,6]]},"reference":[{"key":"BFng1004_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02386711","volume":"7","author":"J Spranger","year":"1978","unstructured":"Spranger, J., Kemperdieck, H., Bakowski, H. & Opitz, J.M. Two peculiar types of enchondromatosis. Pediatr. Radiol. 7, 215\u2013219 (1978).","journal-title":"Pediatr. Radiol."},{"key":"BFng1004_CR2","unstructured":"Lucas, D.R. & Bridge, J.A. Chondromas: enchondroma, periosteal chondroma, and enchondromatosis. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone (eds. Fletcher, C.D.M., Unni, K.K. & Mertens, F.) 237\u2013240 (IARC Press, Lyon, France, 2002)."},{"key":"BFng1004_CR3","first-page":"557","volume":"3","author":"TC Pansuriya","year":"2010","unstructured":"Pansuriya, T.C., Kroon, H.M. & Bovee, J.V.M.G. Enchondromatosis: insights on the different subtypes. Int. J. Clin. Exp. Pathol. 3, 557\u2013569 (2010).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"BFng1004_CR4","doi-asserted-by":"crossref","unstructured":"Verdegaal, S.H.M. et al. Incidence, predictive factors and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist (in the press).","DOI":"10.1634\/theoncologist.2011-0200"},{"key":"BFng1004_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng844","volume":"30","author":"S Hopyan","year":"2002","unstructured":"Hopyan, S. et al. A mutant PTH\/PTHrP type I receptor in enchondromatosis. Nat. Genet. 30, 306\u2013310 (2002).","journal-title":"Nat. Genet."},{"key":"BFng1004_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/humu.20095","volume":"24","author":"LB Rozeman","year":"2004","unstructured":"Rozeman, L.B. et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Hum. Mutat. 24, 466\u2013473 (2004).","journal-title":"Hum. Mutat."},{"key":"BFng1004_CR7","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1093\/hmg\/ddn176","volume":"17","author":"A Couvineau","year":"2008","unstructured":"Couvineau, A. et al. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum. Mol. Genet. 17, 2766\u20132775 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1004_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1172-6-2","volume":"6","author":"TC Pansuriya","year":"2011","unstructured":"Pansuriya, T.C. et al. Genome-wide analysis of Ollier disease: is it all in the genes? Orphanet J. Rare Dis. 6, 2 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFng1004_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/gcc.20889","volume":"50","author":"TC Pansuriya","year":"2011","unstructured":"Pansuriya, T.C. et al. Maffucci syndrome: a genome-wide analysis using high resolution single nucleotide polymorphism and expression arrays on four cases. Genes Chromosom. Cancer 50, 673\u2013679 (2011).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFng1004_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1227\/01.NEU.0000356984.92242.D5","volume":"65","author":"A Ranger","year":"2009","unstructured":"Ranger, A. & Szymczak, A. Do intracranial neoplasms differ in Ollier disease and Maffucci syndrome? An in-depth analysis of the literature. Neurosurgery 65, 1106\u20131113 (2009).","journal-title":"Neurosurgery"},{"key":"BFng1004_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2106\/00004623-198769020-00016","volume":"69","author":"HS Schwartz","year":"1987","unstructured":"Schwartz, H.S. et al. The malignant potential of enchondromatosis. J. Bone Joint Surg. Am. 69, 269\u2013274 (1987).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFng1004_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/PGP.0b013e3181a05af4","volume":"28","author":"L Rietveld","year":"2009","unstructured":"Rietveld, L. et al. First case of juvenile granulosa cell tumor in an adult with Ollier disease. Int. J. Gynecol. Pathol. 28, 464\u2013467 (2009).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"BFng1004_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MPH.0b013e318196a70e","volume":"31","author":"M Leyva-Carmona","year":"2009","unstructured":"Leyva-Carmona, M., Vazquez-Lopez, M.A. & Lendinez-Molinos, F. Ovarian juvenile granulosa cell tumors in infants. J. Pediatr. Hematol. Oncol. 31, 304\u2013306 (2009).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"BFng1004_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765\u2013773 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFng1004_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","volume":"118","author":"C Hartmann","year":"2009","unstructured":"Hartmann, C. et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol. 118, 469\u2013474 (2009).","journal-title":"Acta Neuropathol."},{"key":"BFng1004_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","volume":"16","author":"L Dang","year":"2010","unstructured":"Dang, L., Jin, S. & Su, S.M. IDH mutations in glioma and acute myeloid leukemia. Trends Mol. Med. 16, 387\u2013397 (2010).","journal-title":"Trends Mol. Med."},{"key":"BFng1004_CR17","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1210\/jc.2005-2710","volume":"91","author":"N Kalfa","year":"2006","unstructured":"Kalfa, N. et al. Activating mutations of the stimulatory G protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J. Clin. Endocrinol. Metab. 91, 1842\u20131847 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFng1004_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.2913","volume":"224","author":"MF Amary","year":"2011","unstructured":"Amary, M.F. et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J. Pathol. 224, 334\u2013343 (2011).","journal-title":"J. Pathol."},{"key":"BFng1004_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00428-008-0665-y","volume":"453","author":"JH van Krieken","year":"2008","unstructured":"van Krieken, J.H. et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch. 453, 417\u2013431 (2008).","journal-title":"Virchows Arch."},{"key":"BFng1004_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2144\/000112719","volume":"44","author":"JN Wolff","year":"2008","unstructured":"Wolff, J.N. & Gemmell, N.J. Combining allele-specific fluorescent probes and restriction assay in real-time PCR to achieve SNP scoring beyond allele ratios of 1:1000. Biotechniques 44, 193\u2013194, 196, 199 (2008).","journal-title":"Biotechniques"},{"key":"BFng1004_CR21","doi-asserted-by":"publisher","first-page":"e1000991","DOI":"10.1371\/journal.pgen.1000991","volume":"6","author":"NL Sobreira","year":"2010","unstructured":"Sobreira, N.L. et al. Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet. 6, e1000991 (2010).","journal-title":"PLoS Genet."},{"key":"BFng1004_CR22","doi-asserted-by":"publisher","first-page":"e1002050","DOI":"10.1371\/journal.pgen.1002050","volume":"7","author":"ME Bowen","year":"2011","unstructured":"Bowen, M.E. et al. Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome. PLoS Genet. 7, e1002050 (2011).","journal-title":"PLoS Genet."},{"key":"BFng1004_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ng.749","volume":"43","author":"E Lausch","year":"2011","unstructured":"Lausch, E. et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat. Genet. 43, 132\u2013137 (2011).","journal-title":"Nat. Genet."},{"key":"BFng1004_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ng.748","volume":"43","author":"TA Briggs","year":"2011","unstructured":"Briggs, T.A. et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat. Genet. 43, 127\u2013131 (2011).","journal-title":"Nat. Genet."},{"key":"BFng1004_CR25","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1002\/ajmg.a.33567","volume":"152A","author":"M Collinson","year":"2010","unstructured":"Collinson, M. et al. Symmetrical enchondromatosis is associated with duplication of 12p11.23 to 12p11.22 including PTHLH. Am. J. Med. Genet. A. 152A, 3124\u20133128 (2010).","journal-title":"Am. J. Med. Genet. A."},{"key":"BFng1004_CR26","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1172\/JCI2361","volume":"101","author":"P Bianco","year":"1998","unstructured":"Bianco, P. et al. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J. Clin. Invest. 101, 1737\u20131744 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFng1004_CR27","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1073\/pnas.0910875107","volume":"107","author":"KB Jones","year":"2010","unstructured":"Jones, K.B. et al. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc. Natl. Acad. Sci. USA 107, 2054\u20132059 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1004_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/path.2886","volume":"224","author":"CE de Andrea","year":"2011","unstructured":"de Andrea, C.E., Prins, F.A., Wiweger, M.I. & Hogendoorn, P.C.W. Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage. J. Pathol. 224, 160\u2013168 (2011).","journal-title":"J. Pathol."},{"issue":"27","key":"BFng1004_CR29","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1038\/onc.2011.31","volume":"30","author":"A Terrinoni","year":"2011","unstructured":"de Andrea, C.E. et al. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of the outgrowth of cells with functional EXT. Oncogene published online, doi:10.1038\/onc.2011.311 (1 August 2011).","journal-title":"Oncogene"},{"key":"BFng1004_CR30","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.2353\/ajpath.2010.100296","volume":"177","author":"CM Reijnders","year":"2010","unstructured":"Reijnders, C.M. et al. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am. J. Pathol. 177, 1946\u20131957 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFng1004_CR31","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1073\/pnas.0914431107","volume":"107","author":"JVMG Bov\u00e9e","year":"2010","unstructured":"Bov\u00e9e, J.V.M.G. EXTra hit for mouse osteochondroma. Proc. Natl. Acad. Sci. USA 107, 1813\u20131814 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1004_CR32","doi-asserted-by":"publisher","first-page":"e1000136","DOI":"10.1371\/journal.pgen.1000136","volume":"4","author":"A Cl\u00e9ment","year":"2008","unstructured":"Cl\u00e9ment, A. et al. Regulation of zebrafish skeletogenesis by ext2\/dackel and papst1\/pinscher. PLoS Genet. 4, e1000136 (2008).","journal-title":"PLoS Genet."},{"key":"BFng1004_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/1096-8628(20010201)98:4<290::AID-AJMG1112>3.0.CO;2-F","volume":"98","author":"MM Cohen Jr.","year":"2001","unstructured":"Cohen, M.M. Jr. Fibrous dysplasia is a neoplasm. Am. J. Med. Genet. 98, 290\u2013293 (2001).","journal-title":"Am. J. Med. Genet."},{"key":"BFng1004_CR34","first-page":"2489","volume":"87","author":"SA Lietman","year":"2005","unstructured":"Lietman, S.A., Ding, C. & Levine, M.A. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J. Bone Joint Surg. Am. 87, 2489\u20132494 (2005).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFng1004_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10014-010-0016-y","volume":"28","author":"H Ikota","year":"2011","unstructured":"Ikota, H., Nobusawa, S., Tanaka, Y., Yokoo, H. & Nakazato, Y. High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein. Brain Tumor Pathol. 28, 107\u2013114 (2011).","journal-title":"Brain Tumor Pathol."},{"key":"BFng1004_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa, M.E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553\u2013567 (2010).","journal-title":"Cancer Cell"},{"key":"BFng1004_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/path.2928","volume":"224","author":"DM Thomas","year":"2011","unstructured":"Thomas, D.M. Lessons from the deep study of rare tumours. J. Pathol. 224, 306\u2013308 (2011).","journal-title":"J. Pathol."},{"key":"BFng1004_CR38","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D.W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"BFng1004_CR39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis, E.R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058\u20131066 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFng1004_CR40","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1038\/onc.2010.444","volume":"29","author":"KE Yen","year":"2010","unstructured":"Yen, K.E., Bittinger, M.A., Su, S.M. & Fantin, V.R. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 29, 6409\u20136417 (2010).","journal-title":"Oncogene"},{"key":"BFng1004_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijc.24379","volume":"125","author":"MR Kang","year":"2009","unstructured":"Kang, M.R. et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125, 353\u2013355 (2009).","journal-title":"Int. J. Cancer"},{"key":"BFng1004_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1210\/jc.2009-2170","volume":"95","author":"J Gaal","year":"2010","unstructured":"Gaal, J. et al. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 95, 1274\u20131278 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFng1004_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/EJE-10-0473","volume":"163","author":"JP Hemerly","year":"2010","unstructured":"Hemerly, J.P., Bastos, A.U. & Cerutti, J.M. Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas. Eur. J. Endocrinol. 163, 747\u2013755 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"BFng1004_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744 (2009).","journal-title":"Nature"},{"key":"BFng1004_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510\u2013522 (2010).","journal-title":"Cancer Cell"},{"key":"BFng1004_CR46","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","volume":"96","author":"M Toyota","year":"1999","unstructured":"Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96, 8681\u20138686 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1004_CR47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1440-169X.2007.00940.x","volume":"49","author":"HJ Chin","year":"2007","unstructured":"Chin, H.J. et al. Studies on the role of Dlx5 in regulation of chondrocyte differentiation during endochondral ossification in the developing mouse limb. Dev. Growth Differ. 49, 515\u2013521 (2007).","journal-title":"Dev. Growth Differ."},{"key":"BFng1004_CR48","doi-asserted-by":"publisher","first-page":"e8097","DOI":"10.1371\/journal.pone.0008097","volume":"4","author":"H Zhu","year":"2009","unstructured":"Zhu, H. & Bendall, A.J. Dlx5 is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification. PLoS ONE 4, e8097 (2009).","journal-title":"PLoS ONE"},{"key":"BFng1004_CR49","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbrc.2003.08.058","volume":"309","author":"MH Lee","year":"2003","unstructured":"Lee, M.H., Kwon, T.G., Park, H.S., Wozney, J.M. & Ryoo, H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 309, 689\u2013694 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFng1004_CR50","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1074\/jbc.M704724200","volume":"283","author":"A Ulsamer","year":"2008","unstructured":"Ulsamer, A. et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 283, 3816\u20133826 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFng1004_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00003086-200007000-00038","volume":"376","author":"Sean P. Scully","year":"2000","unstructured":"Scully, S.P. et al. Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma. Clin. Orthop. Relat. Res. 291\u2013303 (2000).","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"BFng1004_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/01.LAB.0000073131.34648.EA","volume":"83","author":"R Gil-Benso","year":"2003","unstructured":"Gil-Benso, R. et al. Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin. Lab. Invest. 83, 877\u2013887 (2003).","journal-title":"Lab. Invest."},{"key":"BFng1004_CR53","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1","volume":"77","author":"T Kunisada","year":"1998","unstructured":"Kunisada, T. et al. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int. J. Cancer 77, 854\u2013859 (1998).","journal-title":"Int. J. Cancer"},{"key":"BFng1004_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00428-004-1194-y","volume":"446","author":"T Kalinski","year":"2005","unstructured":"Kalinski, T. et al. Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. Virchows Arch. 446, 287\u2013299 (2005).","journal-title":"Virchows Arch."},{"key":"BFng1004_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00428-007-0426-3","volume":"451","author":"N Kudo","year":"2007","unstructured":"Kudo, N. et al. Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation. Virchows Arch. 451, 691\u2013699 (2007).","journal-title":"Virchows Arch."},{"key":"BFng1004_CR56","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B","volume":"40","author":"HL Evans","year":"1977","unstructured":"Evans, H.L., Ayala, A.G. & Romsdahl, M.M. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40, 818\u2013831 (1977).","journal-title":"Cancer"},{"key":"BFng1004_CR57","doi-asserted-by":"publisher","first-page":"e17791","DOI":"10.1371\/journal.pone.0017791","volume":"6","author":"R van Eijk","year":"2011","unstructured":"van Eijk, R. et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS ONE 6, e17791 (2011).","journal-title":"PLoS ONE"},{"key":"BFng1004_CR58","doi-asserted-by":"publisher","first-page":"E2036","DOI":"10.1002\/humu.21423","volume":"32","author":"K Szuhai","year":"2011","unstructured":"Szuhai, K. et al. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum. Mutat. 32, E2036\u2013E2049 (2011).","journal-title":"Hum. Mutat."},{"key":"BFng1004_CR59","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2559.2011.03750.x","volume":"58","author":"SL Verbeke","year":"2011","unstructured":"Verbeke, S.L. et al. Distinct histological features characterize primary angiosarcoma of bone. Histopathology 58, 254\u2013264 (2011).","journal-title":"Histopathology"},{"key":"BFng1004_CR60","doi-asserted-by":"crossref","unstructured":"Meijer, D. et al. Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and. in vivo. Clin. Sarcoma Res. 1, 5 (2011).","DOI":"10.1186\/2045-3329-1-5"},{"key":"BFng1004_CR61","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/modpathol.2009.120","volume":"22","author":"LB Rozeman","year":"2009","unstructured":"Rozeman, L.B. et al. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes. Mod. Pathol. 22, 1489\u20131498 (2009).","journal-title":"Mod. Pathol."},{"key":"BFng1004_CR62","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-08-2330","volume":"15","author":"KH Hallor","year":"2009","unstructured":"Hallor, K.H. et al. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin. Cancer Res. 15, 2685\u20132694 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFng1004_CR63","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","volume":"17","author":"EP Buddingh","year":"2011","unstructured":"Buddingh, E.P. et al. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents. Clin. Cancer Res. 17, 2110\u20132119 (2011).","journal-title":"Clin. Cancer Res."},{"key":"BFng1004_CR64","doi-asserted-by":"publisher","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).","journal-title":"Stat. Appl. Genet. Mol. Biol."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.1004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.1004","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.1004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:42:58Z","timestamp":1684442578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.1004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,6]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFng1004"],"URL":"https:\/\/doi.org\/10.1038\/ng.1004","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,6]]}}}